Analyst Price Targets — AVTR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 10:41 am | — | Barclays | $7.00 | $8.18 | TheFly | Avantor price target lowered to $7 from $8.50 at Barclays |
| February 13, 2026 3:46 pm | — | Morgan Stanley | $10.00 | $9.39 | TheFly | Avantor price target lowered to $10 from $12 at Morgan Stanley |
| February 12, 2026 2:31 pm | Dan Leonard | UBS | $10.50 | $9.35 | TheFly | Avantor price target lowered to $10.50 from $13 at UBS |
| February 12, 2026 1:20 pm | — | Stifel Nicolaus | $10.00 | $9.25 | TheFly | Avantor price target lowered to $10 from $12 at Stifel |
| February 12, 2026 1:09 pm | Tycho Peterson | Jefferies | $8.00 | $9.25 | TheFly | Avantor price target lowered to $8 from $9 at Jefferies |
| February 12, 2026 12:55 pm | — | Barclays | $9.00 | $9.64 | TheFly | Avantor price target lowered to $9 from $12 at Barclays |
| February 12, 2026 12:35 pm | — | Robert W. Baird | $11.00 | $9.64 | TheFly | Avantor price target lowered to $11 from $15 at Baird |
| February 11, 2026 4:49 pm | Vijay Kumar | Evercore ISI | $10.00 | $9.32 | TheFly | Avantor price target lowered to $10 from $12 at Evercore ISI |
| January 5, 2026 11:20 am | — | Evercore ISI | $12.00 | $11.46 | TheFly | Avantor downgraded to In Line from Outperform at Evercore ISI |
| December 17, 2025 6:53 am | Tycho Peterson | Jefferies | $9.00 | $11.20 | StreetInsider | Jefferies Downgrades Avantor Inc. (AVTR) to Underperform |
Latest News for AVTR
Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing Company to attend INTERPHEX 2026 in New York City from April 21-23 RADNOR, Pa., April 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology…
During the quarter, we had no new purchases and exited three holdings: Louisiana-Pacific, PayPal and Walt Disney. CNH, a leading global agriculture and construction equipment manufacturer, was a contributor for the quarter. Life-sciences company Avantor detracted for the quarter.
AVTR stock gains after expanding U.S. lab capabilities, boosting biopharma support, streamlining testing and strengthening supply chain efficiency.
St. Louis site strengthens integrated support for biopharma manufacturing RADNOR, Pa., April 13, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the expansion of its North American quality control capabilities with the addition of advanced microbial and stability…
First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and Avantor (NYSE: AVTR - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 95.1% of Avantor
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVTR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.